Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioNexus Gene Lab Corp (BGLC)
NASDAQ:BGLC
Holding BGLC?
Track your performance easily
BGLC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.31 - $3.39
Previous Close$0.44
Volume60.95K
Average Volume (3M)180.87K
Market Cap
$7.91M
Enterprise Value$5.94M
Total Cash (Recent Filing)$2.20M
Total Debt (Recent Filing)$235.91K
Price to Earnings (P/E)―
Beta1.30
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding17,967,663
10 Day Avg. Volume191,162
30 Day Avg. Volume180,865
Standard Deviation0.32
R-Squared0.08
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.85
Price to Sales (P/S)0.81
Price to Cash Flow (P/CF)-57.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.63
Enterprise Value/Gross Profit4.47
Enterprise Value/Ebitda-2.37
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioNexus Gene Lab Corp News
PremiumCompany Announcements
BioNexus Receives Government Backing for Healthcare Tech
PremiumCompany Announcements
BioNexus Gene Lab’s Strategic Investment in AI Healthcare
PremiumCompany Announcements
BioNexus Gene Lab Expands Reach with Strategic InvestmentPremiumCompany Announcements
BioNexus Gene Lab Announces Major Board and Leadership Restructuring
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.13% Mutual Funds
0.15% Other Institutional Investors
99.72% Public Companies and
Individual Investors
BGLC FAQ
What was BioNexus Gene Lab Corp’s price range in the past 12 months?
BioNexus Gene Lab Corp lowest stock price was $0.31 and its highest was $3.39 in the past 12 months.
What is BioNexus Gene Lab Corp’s market cap?
Currently, no data Available
When is BioNexus Gene Lab Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BioNexus Gene Lab Corp’s earnings last quarter?
Currently, no data Available
Is BioNexus Gene Lab Corp overvalued?
According to Wall Street analysts BioNexus Gene Lab Corp’s price is currently Overvalued.
Does BioNexus Gene Lab Corp pay dividends?
BioNexus Gene Lab Corp does not currently pay dividends.
What is BioNexus Gene Lab Corp’s EPS estimate?
BioNexus Gene Lab Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioNexus Gene Lab Corp have?
BioNexus Gene Lab Corp has 17,967,663 shares outstanding.
What happened to BioNexus Gene Lab Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BioNexus Gene Lab Corp?
Currently, no hedge funds are holding shares in BGLC
---
BioNexus Gene Lab Corp Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-72.50%
12-Months-Change
Fundamentals
Return on Equity
-28.44%
Trailing 12-Months
Asset Growth
41.03%
Trailing 12-Months
Company Description
BioNexus Gene Lab Corp
BioNexus Gene Lab Corp is an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management. It focuses on developing and marketing safe, effective, and non-invasive blood tests for the early detection of diseases. The company's non-invasive blood tests analyze changes in ribonucleic acid (or RNA) to detect the potentiality of 11 different diseases. These diseases include eight cancers (nasopharyngeal, lung, liver, stomach, breast, cervical, prostate, and colon), two bowel diseases (colitis and Crohn), and osteoarthritis.
---
Technical Analysis
---